Skip to main content

Practice Tips

  • FDA approves Espero Pharmaceuticals’ Gonitro sublingual powder

    SILVER SPRING, Md. — The Food and Drug Administration has approved Espero Pharmaceuticals’ Gonitro (nitroglycerin), the company announced Tuesday. Gonitro is indicated to prevent or provide acute relief for an attack of angina pectoris due to coronary artery disease and it is available in single-dose packets of a short-acting nitrate in a stabilized crystal granule form. 
     

  • Greenstone launches authorized Tikosyn generic

    PEAPACK, N.J. — Greenstone on Friday announced the introduction of its authorized generic of Tikosyn (dofetilide) capsules. The drug is indicated for the maintenance of normal sinus rhythm in patients with atrial fibrillation/atrial flutter of greater than one week who have been converted to normal sinus rhythm. 
     
    Greenstone's dofetilide will be available in 60-count bottles of 0.125-, 0.250- and 0.5-mg dosage strength capsules.
     

  • FDA gives Upsher-Smith tentative approval for new Qudexy XR indication

    SILVER SPRING, Md. — The Food and Drug Administration has granted tentative approval to Upsher-Smith Laboratories’ application for a new indication for its Qudexy XR (topiramate) extended-release capsules as a preventative therapy for migraine headaches. 
     

  • Mylan launches generic Cleocin

    PITTSBURGH — Mylan on Friday launched its generic of Cleocin (clindamycin palmitate hydrochloride) solution. The drug is indicated to treat serious infections caused by susceptible anaerobic bacteria and susceptible strains of streptococci, pneumococci and staphylococci when less toxic alternatives aren’t appropriate. 
     
    The product had U.S. sales of about $30.9 billion for the 12 months ended March 31, according to IMS Health. Mylan’s generic will be available as a 75 mg/5 mL oral solution. 
     

  • Promius Pharma launches Sernivo Spray

    PRINCETON, N.J. — Dr. Reddy’s Laboratory subsidiary Promius Pharma on Wednesday announced the launch of its Sernivo Spray (betamethasone dipropionate). 
     
    The topical steroid is indicated to treat mild to moderate plaque psoriasis in patients older than 18 years of age. 
     

  • APhA names prominent pharmacy educator president-elect for 2017-2018

    WASHINGTON - The American Pharmacists Association last week announced the election of Nicki Hilliard of Little Rock, Ark., as 2017–2018 APhA president-elect. Hilliard will succeed Nancy Alvarez of Lake Forest, Calif., to the office of APhA president on March 19, 2018, at the end of the 2018 APhA Annual Meeting & Exposition in Nashville, Tenn.

    Also elected to serve three-year terms on APhA’s board of trustees are Sandra Leal of Tucson, Ariz., and Randy McDonough, of Iowa City, Iowa. Both terms will begin in March 2017.

  • Hamacher Resource Group to examine shifts in healthcare system

    WAUKESHA, Wis. – Hamacher Resource Group will examine the shift in our healthcare system from a professional healthcare setting to self-management and home-based care in the first of two upcoming GMDC Infocasts on Thursday, June 2, from 1 p.m. to 2 p.m., EDT.

    The research will look at the transfer of empowerment in the healthcare continuum as more patients take control of their health decisions and needs, and as family members (non-trained caregivers) are becoming part of the healthcare team.

  • Quality Specialty Pharmacy receives full specialty accreditation from URAC

    WASHINGTON — Independent retail and specialty pharmacy chain Quality Specialty Pharmacy recently announced that it had received full Specialty Pharmacy Accreditation from URAC. 

X
This ad will auto-close in 10 seconds